Bone Biologics Stock Forecast - Daily Balance Of Power
| BBLG Stock | USD 1.01 0.04 3.81% |
Bone Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Bone Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Bone |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.3478 | 0.7778 |
| Check Bone Biologics Volatility | Backtest Bone Biologics | Trend Details |
Bone Biologics Trading Date Momentum
| On September 21 2023 Bone Biologics Corp was traded for 6.08 at the closing time. The top price for the day was 6.24 and the lowest listed price was 5.76 . The trading volume for the day was 6.3 K. The trading history from September 21, 2023 did not affect price variability. The overall trading delta against the current closing price is 4.61% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Bone Biologics to competition |
Other Forecasting Options for Bone Biologics
For every potential investor in Bone, whether a beginner or expert, Bone Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bone Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bone. Basic forecasting techniques help filter out the noise by identifying Bone Biologics' price trends.Bone Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bone Biologics stock to make a market-neutral strategy. Peer analysis of Bone Biologics could also be used in its relative valuation, which is a method of valuing Bone Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bone Biologics Corp Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bone Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bone Biologics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bone Biologics Market Strength Events
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns.
Bone Biologics Risk Indicators
The analysis of Bone Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bone Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bone stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.36 | |||
| Standard Deviation | 7.98 | |||
| Variance | 63.6 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Bone Biologics Corp is a strong investment it is important to analyze Bone Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bone Biologics' future performance. For an informed investment choice regarding Bone Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Bone Biologics to cross-verify your projections. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Return On Assets (0.57) | Return On Equity (1.19) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.